Biogen trims annual profit forecast on expected hit from R&D-related charges

Core Viewpoint - Biogen has lowered its annual profit forecast due to anticipated R&D related charges from acquisitions, expecting a hit of $1.25 per share in the fourth quarter [1] Financial Impact - The company expects a reduction of $1.25 per share in its earnings due to R&D related charges [1]